Latest News and Press Releases

Press ReleaseSource: Sanofi (EURONEXT: SAN) (NASDAQ: SNY)     Availability of the Pre-quarterly Results Communication   Paris, France - April 1, 2019 -...

PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES AN AGREEMENT WITH BIOSYN GmbH        TO DIVERSIFY ITS SUPPLY OF KEYHOLE LIMPET HEMOCYANIN (KLH)   Paris et Boston, april...

Viking Line Abp     NOTICE TO GENERAL MEETING     1.4.2019, 8.30 AM Invitation to the Annual General Meeting The shareholders in Viking Line Abp are invited to the Annual General Meeting,...

                                      BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...

                                      BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, OR JAPAN OR INTO ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH...

Acquisition will give Novartis one clinical and two preclinical programs targeting the NLRP3 inflammasome, a key component of the innate immune system  Selective inhibition of the NLRP3...

LONDON, 01 Apr. 2019 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by West Corporation and is designated by the FCA as an approved primary...

Data from Phase Ib study to be presented at American Association for Cancer Research (AACR) 2019 annual congress 73% overall response rate (ORR) irrespective of PD-L1 status or PI3KCA/AKT1/PTEN...

INNATE PHARMA HIGHLIGHTS NEXT GENERATION OF CANCER IMMUNOTHERAPIES AT THE AMERICAN ASSOCIATION OF CANCER RESEARCH (AACR) 2019 ANNUAL MEETING New preclinical data highlights IPH5201 (anti-CD39) and...